Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06145321 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

StatusActive, Not Recruiting
PhasePhase 4
Started2023-11-23
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated November 15, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2024-09-11
Recruiting→Active, Not Recruiting Study Status, Sponsor/Collaborators, Study Design, Contacts/Locations v3
Trial statusRecruiting→Active, Not Recruiting
Enrollment targetestimated 40→confirmed 20
Study sitesdetails revised at 1 of 1 site
2024-02-25
Study Status, Outcome Measures v2
Re-verified, no change to tracked fields
2024-02-16
Study Status v1
Start dateestimated 2023-11-16→confirmed 2023-11-23
2023-11-21
Original filing
The investigators hypothesized that in terms of granulocyte colony-stimulating factor (G-CSF) administration, the route of continuous infusion would lead to a faster neutrophil recovery compared to that of bolus administration
Trial Details
NCT Number NCT06145321
Lead Sponsor Chang Gung Memorial Hospital
Conditions Pediatric Cancer, Neutropenia, Lenograstim, Filgrastim, G-CSF
Enrollment 20 participants
Start Date 2023-11-23
Primary Completion 2024-11-15 (estimated)
Study Completion 2024-11-15 (estimated)
Updated on ClinicalTrials.gov 2024-09-19